The expression of the proliferating antigen Ki67, PCNA and products of suppressor gene p53 in primary invasive ductal breast carcinoma.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Journal of experimental & clinical cancer research : CR

• Publication date

  1998-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 10089075
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Proliferating-cell nuclear antigen (PC10) immunolabelling and other proliferation indices as prognostic factors in breast cancer

  2005cited by this paper
• Prognostic significance of p53 gene alterations in node-negative breast cancer

  2004cited by this paper
• Mechanisms of hormone resistance in breast cancer

  2004cited by this paper
• A hospital-based case-control study of breast-cancer risk factors by estrogen and progesterone receptor status

  2004cited by this paper
• P53 gene mutations and steroid receptor status in breast cancer. Clinicopathologic correlations and prognostic assessment

  1994cited by this paper
• p53 immunohistochemical analysis in breast cancer with four monoclonal antibodies: comparison of staining and PCR-SSCP results.

  1994cited by this paper
• Rising levels of estrogen receptor in breast cancer over 2 decades

  1994cited by this paper
• p53 protein and vimentin in invasive ductal NOS breast carcinoma--relationship with survival and sites of metastases.

  1994cited by this paper
• Expression of proliferating cell nuclear antigen, Ki‐67 antigen, estrogen receptor protein, and tumor suppressor p53 gene in cytologic samples of breast cancer: An immunochemical study with clinical, pathobiological, and histologic correlations

  1994cited by this paper
• Relationship of patient age to pathologic features of the tumor and prognosis for patients with stage I or II breast cancer.

  1994cited by this paper
• Estrogen receptors (ER) in human breast cancer. The significance of a new prognostic factor based on both ER protein and ER mRNA contents

  1994cited by this paper
• Prognostic factors in early breast carcinoma

  1994cited by this paper
• Cell kinetics in human breast cancer: Comparison between the prognostic value of the cytofluorimetric S‐phase fraction and that of the antibodies to Ki‐67 and PCNA antigens detected by immunocytochemistry

  1994cited by this paper
• Cell proliferation in breast carcinoma assessed by a PCNA grading system and its relation to other prognostic variables.

  1993cited by this paper
• Prognostic significance of TP53 alterations in breast carcinoma.

  1993cited by this paper
• Prognostic value of Ki-67 immunolabelling in primary operable breast cancer.

  1993cited by this paper
• Prognostic value of proliferating cell nuclear antigen in lymph node—negative breast cancer patients

  1993cited by this paper
• Overexpression of p53 and prognosis in breast cancer

  1993cited by this paper
• Cellular oncogenes and suppressor genes as prognostic markers in cancer.

  1993cited by this paper
• Prediction of early relapse and shortened survival in patients with breast cancer by proliferating cell nuclear antigen score

  1993cited by this paper
• A new proliferation-associated nuclear antigen detectable in paraffin-embedded tissues by the monoclonal antibody Ki-S1.

  1993cited by this paper
• Immunohistochemical detection of p53 protein in mammary carcinoma: an important new independent indicator of prognosis?

  1993cited by this paper
• Nuclear p53 protein accumulates preferentially in medullary and high-grade ductal but rarely in lobular breast carcinomas.

  1993cited by this paper
• Value of epidermal growth factor receptor status compared with growth fraction and other factors for prognosis in early breast cancer.

  1992cited by this paper
• Age as a determinant of axillary node involvement in invasive breast cancer.

  1992cited by this paper
• Prognostic value of epidermal growth factor receptor in a series of 303 breast cancers.

  1992cited by this paper
• PCNA and Ki67 expression in breast carcinoma: correlations with clinical and biological variables.

  1992cited by this paper
• Sequential estrogen receptor determinations from primary breast cancer and at relapse: prognostic and therapeutic relevance. The International Breast Cancer Study Group (formerly Ludwig Group).

  1992cited by this paper
• Ki67 immunoreactivity in breast carcinoma: relationships to prognostic variables and short term survival.

  1992cited by this paper
• Relation between p53 overexpression and established prognostic factors in breast cancer.

  1991cited by this paper
• A meta-analysis of reported correlations between prognostic factors in breast cancer: does axillary lymph node metastasis represent biology or chronology?

  1991cited by this paper
• Breast cancer cell kinetics: immunocytochemical determination of growth fractions by monoclonal antibody Ki-67 and correlation with flow cytometric S-phase and with some features of tumor aggressiveness.

  1991cited by this paper

• Intracystic papillary carcinoma of the breast: Experience of a major Chinese cancer center.

  2018cites this paper
• Intracellular Iron Chelation Modulates the Macrophage Iron Phenotype with Consequences on Tumor Progression

  2016cites this paper
• RSK4 knockdown promotes proliferation, migration and metastasis of human breast adenocarcinoma cells.

  2015cites this paper
• Protection of MES23.5 dopaminergic cells by obestatin is mediated by proliferative rather than anti-apoptotic action

  2014cites this paper
• Associação do índice de proliferação e de apoptose celular com características clínicas, epidemiológicas e histopatológicas do câncer mamário de cadelas sem raça definida

  2007cites this paper
• The relationship between the termination of cell proliferation and expression of heat-shock protein-25 in the rat developing tooth germ.

  2006cites this paper
• Effect of retinol on radiation- and estrogen-induced neoplastic transformation of human breast epithelial cells.

  2005cites this paper
• Ethnicity and breast cancer in Hawaii: increased survival but continued disparity.

  2005cites this paper
• Immunochemical analysis of protein expression in breast epithelial cells transformed by estrogens and high linear energy transfer (LET) radiation

  2005cites this paper
• Ethnic differences in breast cancer in Hawai'i: age, stage, hormone receptor status, and survival.

  2004cites this paper
• Cytosolic thymidine kinase is a specific histopathologic tumour marker for breast carcinomas.

  2004cites this paper
• A Comparative Study: Immunohistochemical Detection of Cytosolic Thymidine Kinase and Proliferating Cell Nuclear Antigen in Breast Cancer

  2002cites this paper
• Prognostic value of combined analysis of estrogen receptor status and cellular proliferative activity in breast cancer patients with extensive lymph node metastases.

  2002cites this paper
• Proliferating cell nuclear antigen labeling index and p53 expression predict outcome for breast cancer patients with four or more lymph node metastases.

  2001cites this paper